175 related articles for article (PubMed ID: 34819993)
1. SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma.
Chang Q; Xu Y; Wang J; Jing H; Rao L; Tang W; Zhang Z; Wu X
Comput Math Methods Med; 2021; 2021():8556888. PubMed ID: 34819993
[TBL] [Abstract][Full Text] [Related]
2. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
[TBL] [Abstract][Full Text] [Related]
3. A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma.
Wang J; Huang Z; Lu H; Zhang R; Feng Q; He A
Comput Math Methods Med; 2022; 2022():1258480. PubMed ID: 35242200
[TBL] [Abstract][Full Text] [Related]
4. Upregulation Mitochondrial Carrier 1 (MTCH1) Is Associated with Cell Proliferation, Invasion, and Migration of Liver Hepatocellular Carcinoma.
Chen G; Mo S; Yuan D
Biomed Res Int; 2021; 2021():9911784. PubMed ID: 34195286
[TBL] [Abstract][Full Text] [Related]
5. Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index.
Bai KH; He SY; Shu LL; Wang WD; Lin SY; Zhang QY; Li L; Cheng L; Dai YJ
Cancer Med; 2020 Jun; 9(12):4290-4298. PubMed ID: 32311840
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma.
Shi L; Shang X; Nie K; Lin Z; Zheng M; Wang M; Yuan H; Zhu Z
J Clin Pathol; 2021 Aug; 74(8):504-512. PubMed ID: 33004423
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic significance and carcinogenic mechanism of pan-cancer gene POU5F1 in liver hepatocellular carcinoma.
He D; Zhang X; Tu J
Cancer Med; 2020 Dec; 9(23):8782-8800. PubMed ID: 32978904
[TBL] [Abstract][Full Text] [Related]
8. Exploring the role of CDCA4 in liver hepatocellular carcinoma using bioinformatics analysis and experiments.
Liang C; Long K; Zheng W; Zhong R; Li Z; Zhu S; Gu S; Zhu C; Yang Y
Medicine (Baltimore); 2024 May; 103(18):e38028. PubMed ID: 38701314
[TBL] [Abstract][Full Text] [Related]
9. Study of the G Protein Nucleolar 2 Value in Liver Hepatocellular Carcinoma Treatment and Prognosis.
Dong Y; Cai Q; Fu L; Liu H; Ma M; Wu X
Biomed Res Int; 2021; 2021():4873678. PubMed ID: 34337013
[TBL] [Abstract][Full Text] [Related]
10. PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma.
Jin W; Wang G; Dong M; Wang X
Eur J Med Res; 2024 Mar; 29(1):177. PubMed ID: 38494503
[TBL] [Abstract][Full Text] [Related]
11. Silencing of the
Zhang J; Ma H; Yang L; Yang H; He Z
J Int Med Res; 2019 Mar; 47(3):1319-1329. PubMed ID: 30678511
[TBL] [Abstract][Full Text] [Related]
12. The prognostic and antitumor roles of key genes of ferroptosis in liver hepatocellular cancer and stomach adenocarcinoma.
Pei W; Jiang M; Liu H; Song J; Hu J
Cancer Biomark; 2024; 39(4):335-347. PubMed ID: 38393890
[TBL] [Abstract][Full Text] [Related]
13. RNA sequencing reveals the long noncoding RNA and mRNA profiles and identifies long non-coding RNA TSPAN12 as a potential microvascular invasion-related biomarker in hepatocellular carcinoma.
Lu J; Li B; Xiong X; Cheng N
Biomed Pharmacother; 2020 Jun; 126():110111. PubMed ID: 32222644
[TBL] [Abstract][Full Text] [Related]
14. Overexpressed Histocompatibility Minor 13 was Associated with Liver Hepatocellular Carcinoma Progression and Prognosis.
Zong RQ; Zhang HY; Li XY; Li YR; Chen Y
Genet Res (Camb); 2022; 2022():7067743. PubMed ID: 36262249
[TBL] [Abstract][Full Text] [Related]
15. CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma.
Li L; Huang K; Zhao H; Chen B; Ye Q; Yue J
Cell Cycle; 2020 May; 19(10):1236-1252. PubMed ID: 32275843
[TBL] [Abstract][Full Text] [Related]
16. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Prognostic and Immune Analysis of SLC41A3 in Pan-Cancer.
Liu J; Zhang S; Dai W; Xie C; Li JC
Front Oncol; 2020; 10():586414. PubMed ID: 33520701
[TBL] [Abstract][Full Text] [Related]
18. METTL3-mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis.
Wang A; Chen X; Li D; Yang L; Jiang J
J Clin Lab Anal; 2021 Sep; 35(9):e23931. PubMed ID: 34398984
[TBL] [Abstract][Full Text] [Related]
19. Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion.
Zhang R; Huang M; Wang H; Wu S; Yao J; Ge Y; Lu Y; Hu Q
Pathol Oncol Res; 2021; 27():597527. PubMed ID: 34257549
[No Abstract] [Full Text] [Related]
20. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]